European Organisation For Research & Treatment Of Cancer
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2022-09-15
- Target Recruit Count
- 156
- Registration Number
- NCT02856893
- Locations
- 🇫🇷
CHU de Brest, Brest, France
🇵🇱Medical University of Gdansk, Gdansk, Poland
🇫🇷Institut Paoli-Calmettes, Marseille, France
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Conditions
- All Tumor Types
- Interventions
- Genetic: RP-1843 ArcagenGenetic: RP-1828 IMMUcanGenetic: RP-1920 BioRadonGenetic: RP-1759 AYA/TYA
- First Posted Date
- 2016-07-15
- Last Posted Date
- 2025-05-01
- Target Recruit Count
- 4975
- Registration Number
- NCT02834884
- Locations
- 🇫🇷
CHU de Bordeaux - Groupe Hospitalier Saint-Andre - Hopital Saint-Andre, Bordeaux, France
🇨🇿University Hospital Motol, Prague, Czechia
🇫🇷Centre Eugene Marquis, Rennes, France
Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2021-09-20
- Target Recruit Count
- 80
- Registration Number
- NCT02808247
- Locations
- 🇧🇪
Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels, Belgium
🇫🇷Institut Bergonie, Bordeaux, France
🇧🇪Cliniques Universitaires Saint-Luc (121), Brussels, Belgium
Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2024-11-05
- Target Recruit Count
- 885
- Registration Number
- NCT02799706
- Locations
- 🇧🇪
Hopitaux Universitaires Bordet-Erasme - Hopitaux Universitaires Bordet- Institut Jules Bordet, Brussels, Belgium
🇧🇪Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme, Brussels, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Brussels, Belgium
Diffusion-Weighted MRI for Liver Metastasis
- Conditions
- Malignant Neoplasm of Rectum Metastatic to LiverColorectal CancerColon Cancer Liver Metastasis
- First Posted Date
- 2016-05-25
- Last Posted Date
- 2024-01-05
- Target Recruit Count
- 233
- Registration Number
- NCT02781935
- Locations
- 🇯🇵
Gunma Cancer Center, Ota-City, Japan
🇯🇵Hyogo College of Medicine, Hyōgo, Japan
🇯🇵Niigata Prefectural Cancer Center Hospital, Niigata, Japan
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
- Conditions
- Ovarian Neoplasms
- Interventions
- First Posted Date
- 2016-01-20
- Last Posted Date
- 2023-03-14
- Target Recruit Count
- 122
- Registration Number
- NCT02659384
- Locations
- 🇳🇱
Leiden University Medical Centre, Leiden, Netherlands
🇨🇭Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇬🇧Guy's and St Thomas' NHS - Guy s and St Thomas' NHS - Guy's Hospital, London, United Kingdom
Pembrolizumab in Untreated Extensive SCLC
- Conditions
- Small Cell Lung Cancer (SCLC)
- Interventions
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2023-12-11
- Target Recruit Count
- 125
- Registration Number
- NCT02580994
- Locations
- 🇮🇹
Ospedale S. Luigi Gonzaga - Universita Di Torino, Orbassano, Italy
🇫🇷Centre Hospitalier d'Avignon - Hopital Duffaut, Avignon, France
🇫🇷Centre Hopitalier Intercommunal De Creteil, Créteil, France
SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access
- Conditions
- Melanoma
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
- Conditions
- Uterine Cervical Neoplasms
- Interventions
- Radiation: Radiotherapy (Extrernal beam radiotherapy + brachytherapy)Biological: INO-3112 vaccine
- Locations
- 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Procedure: Immediate surgery
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2016-01-22
- Target Recruit Count
- 38
- Registration Number
- NCT02470065